- Home
- LSTA vs HOTH Comparison
LSTA vs HOTH Comparison
Compare LSTA & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- HOTH
- Stock Information
- Founded
- LSTA 1980
- HOTH 2017
- Country
- LSTA United States
- HOTH United States
- Employees
- LSTA N/A
- HOTH N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- HOTH Health Care
- Exchange
- LSTA Nasdaq
- HOTH Nasdaq
- Market Cap
- LSTA 20.9M
- HOTH 18.0M
- IPO Year
- LSTA N/A
- HOTH 2019
- Fundamental
- Price
- LSTA $2.06
- HOTH $1.25
- Analyst Decision
- LSTA Strong Buy
- HOTH Strong Buy
- Analyst Count
- LSTA 2
- HOTH 2
- Target Price
- LSTA $23.50
- HOTH $4.50
- AVG Volume (30 Days)
- LSTA 144.6K
- HOTH 609.0K
- Earning Date
- LSTA 11-06-2025
- HOTH 11-11-2025
- Dividend Yield
- LSTA N/A
- HOTH N/A
- EPS Growth
- LSTA N/A
- HOTH N/A
- EPS
- LSTA N/A
- HOTH N/A
- Revenue
- LSTA $1,070,000.00
- HOTH N/A
- Revenue This Year
- LSTA N/A
- HOTH N/A
- Revenue Next Year
- LSTA N/A
- HOTH N/A
- P/E Ratio
- LSTA N/A
- HOTH N/A
- Revenue Growth
- LSTA N/A
- HOTH N/A
- 52 Week Low
- LSTA $1.87
- HOTH $0.66
- 52 Week High
- LSTA $4.20
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- LSTA 35.02
- HOTH 32.66
- Support Level
- LSTA $2.00
- HOTH $1.34
- Resistance Level
- LSTA $2.98
- HOTH $1.43
- Average True Range (ATR)
- LSTA 0.23
- HOTH 0.08
- MACD
- LSTA -0.05
- HOTH -0.01
- Stochastic Oscillator
- LSTA 9.18
- HOTH 15.59
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).